Turner syndrome: Transition from pediatrics to adulthood

Endocrine Practice

Volumn 14, Issue 6, 2008, Pages 775-781

  Rubin, Karen R ^a,b  

^a Farmington   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; ESTROGEN THERAPY; HEALTH BEHAVIOR; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; LONGEVITY; METABOLIC SYNDROME X; OSTEOPENIA; OSTEOPOROSIS; PATIENT AUTONOMY; PATIENT MONITORING; PSYCHOLOGICAL ASPECT; REVIEW; SELF CARE; THYROID DISEASE; TREATMENT PLANNING; TURNER SYNDROME; AGE; CHILD; DRUG ADMINISTRATION ROUTE; METABOLISM; PATHOLOGY;

ADOLESCENT; AGE FACTORS; CHILD; DRUG ADMINISTRATION ROUTES; ESTROGEN REPLACEMENT THERAPY; GROWTH HORMONE; HUMANS; METABOLIC SYNDROME X; TURNER SYNDROME;

EID: 64749084466     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.6.775     Document Type: Review

References (41)

1. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G (Italian Study Group for Turner's Syndrome). Spontaneous pubertal development in Turner's syndrome. J Clin Endocrinol Metab. 1997;82:1810-1813.
2. Carel JC, Ecosse E, Bastie-Sigeac I, et al. Quality of life determinants in young women with Turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab. 2005;90:1992-1997.
3. Boman UW, Bryman I, Möller A. Psychological well-being in women with Turner syndrome: somatic and social correlates. J Psychosom Obstet Gynaecol. 2004;25:211-219.
4. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J (Genentech, Inc., Collaborative Study Group). Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final adult height. J Clin Endocrinol Metab. 2000;85:2439-2445.
5. Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T Jr, Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab. 2005;90:6424-6430.
6. Drobac S, Rubin K, Rogol AD, Rosenfield RL. A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab. 2006;19:55-64.
7. Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab. 2001;86:3039-3044.
8. Piippo S, Lenko H, Kainulainen P, Sipilä I. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab. 2004;89:3241-3247.
9. Rossouw JE, Anderson GL, Prentice RL, et al (Writing Group for the Women's Health Initiative Investigators). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
10. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51:147-158.
11. Caprio S, Boulware S, Diamond M, et al. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab. 1991;72:832-836.
12. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL (Dutch Advisory Group on Growth Hormone). Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. J Clin Endocrinol Metab. 2000;85:769-775.
13. Bakalov VK, Cooley MM, Quon MJ, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab. 2004;89:3516-3520.
14. Ostberg JE, Thomas EL, Hamilton G, Attar MJ, Bell JD, Conway GS. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab. 2005;90:2631-2635.
15. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab. 2001;86:4166-4170.
16. Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome: the impact of sex hormone replacement. Diabetes Care. 1998;21:1062-1070.
17. Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB Jr. Lipid abnormalities in Turner syndrome. J Pediatr. 1995;126:242-245.
18. Lanes R, Gunczler P, Palacios A, Villaroel O. Serum lipids, lipoprotein Lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Fertil Steril. 1997;68:473-477.
19. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child. 1994;71:433-436.
20. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101:E11.
21. Mazzanti L, Cacciari E (Italian Study Group for Turner Syndrome [ISGTS]). Congenital heart disease in patients with Turner's syndrome. J Pediatr. 1998;133:688-692.
22. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998;102:E12.
23. Rubin K. Aortic dissection and rupture in Turner syndrome. J Pediatr. 1993;122:670.
24. Ostberg JE, Brockes JA, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab. 2004;89:5966-5971.
25. Ho VB, Bakalov VK, Cooley M, et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation. 2004;110:1694-1700.
26. Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner syndrome: arterial dilatation of intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab. 2005;90:5161-5166.
27. Bondy CA (Turner Syndrome Study Group). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10-25.
28. Nagel TC, Tesch LG. ART and high risk patients! Fertil Steril. 1997;68:748-749.
29. Bakalov VK, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab. 2003;88:5717-5722.
30. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf). 2003;59:89-96.
31. Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol. 1996;134:568-575.
32. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. Hypothyroidism is common in Turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab. 2005;90:2131-2135.
33. Bonamico M, Pasquino AM, Mariani P, et al (Italian Society of Pediatric Gastroenterology Hepatology [SIGEP]; Italian Study Group for Turner Syndrome [ISGTS]). Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495-5498.
34. Elsheikh M, Conway GS, Wass JA. Medical problems in adult women with Turner's syndrome. Ann Med. 1999;31:99-105.
35. Bilge I, Kayserili H, Emre S, et al. Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children. Pediatr Nephrol. 2000;14:1111-1114.
36. Sylvén L, Hagenfeldt K, Bröndum-Nielsen K, von Schoultz B. Middle-aged women with Turner's syndrome: medical status, hormonal treatment and social life. Acta Endocrinol (Copenh). 1991;125:359-365.
37. Elsheikh M, Hodgson HJ, Wass TA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf). 2001;55:227-231.
38. Ross JL, Stefanatos GA, Kushner H, Zinn A, Bondy C, Roeltgen D. Persistent cognitive deficits in adult women with Turner syndrome. Neurology. 2002;58:218-225.
39. McCauley E, Ito J, Kay T. Psychosocial functioning in girls with Turner's syndrome and short stature: social skills, behavioral problems, and self-concept. J Am Acad Child Psychiatry. 1986;25:105-112.
40. Rovet JF. The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil. 1993;26:333-341.
41. Pavlidis K, McCauley E, Sybert VP. Psychosocial and sexual functioning in women with Turner syndrome. Clin Genet. 1995;47:85-89.